LncRNA-MALAT1: A Key Participant in the Occurrence and Development of Cancer

被引:27
作者
Hao, Longhui [1 ]
Wu, Wenzheng [1 ]
Xu, Yankun [1 ]
Chen, Yufan [2 ]
Meng, Chengzhen [2 ]
Yun, Jingyi [1 ]
Wang, Xiaoyu [1 ]
机构
[1] Shandong Univ Tradit Chinese Med, Coll Pharm, Jinan 250355, Peoples R China
[2] Shandong Univ Tradit Chinese Med, Coll Tradit Chinese Med, Jinan 250355, Peoples R China
来源
MOLECULES | 2023年 / 28卷 / 05期
基金
中国国家自然科学基金;
关键词
long non-coding RNA; lncRNA-MALAT1; cancer; mechanism; action pathway; LONG NONCODING RNA; LNCRNA MALAT1;
D O I
10.3390/molecules28052126
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
LncRNAs are a group of non-coding RNA transcripts with lengths of over 200 nucleotides and can interact with DNA, RNA, and proteins to regulate gene expression of malignant tumors in human tissues. LncRNAs participate in vital processes, such as chromosomal nuclear transport in the cancerous site of human tissue, activation, and the regulation of proto-oncogenes, the differentiation of immune cells, and the regulation of the cellular immune system. The lncRNA metastasis-associated lung cancer transcript 1 (MALAT1) is reportedly involved in the occurrence and development of many cancers and serves as a biomarker and therapeutic target. These findings highlight its promising role in cancer treatment. In this article, we comprehensively summarized the structure and functions of lncRNA, notably the discoveries of lncRNA-MALAT1 in different cancers, the action mechanisms, and the ongoing research on new drug development. We believe our review would serve as a basis for further research on the pathological mechanism of lncRNA-MALAT1 in cancer and provide evidence and novel insights into its application in clinical diagnoses and treatments.
引用
收藏
页数:14
相关论文
共 65 条
[1]   Lung Cancer 2020 Epidemiology, Etiology, and Prevention [J].
Bade, Brett C. ;
Dela Cruz, Charles S. .
CLINICS IN CHEST MEDICINE, 2020, 41 (01) :1-+
[2]   Epigenetic-based therapy: From single- to multi-target approaches [J].
Benedetti, Rosaria ;
Conte, Mariarosaria ;
Iside, Concetta ;
Altucci, Lucia .
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2015, 69 :121-131
[3]   Long Noncoding RNA and Cancer: A New Paradigm [J].
Bhan, Arunoday ;
Soleimani, Milad ;
Mandal, Subhrangsu S. .
CANCER RESEARCH, 2017, 77 (15) :3965-3981
[4]   PLAC8 Overexpression Promotes Lung Cancer Cell Growth via Wnt/β-Catenin Signaling [J].
Chen, Wei ;
Wu, Junlu ;
Wang, Weiwei ;
Yu, Li ;
Xu, Xianghuai .
JOURNAL OF IMMUNOLOGY RESEARCH, 2022, 2022
[5]   High Expression of EZH2 Mediated by ncRNAs Correlates with Poor Prognosis and Tumor Immune Infiltration of Hepatocellular Carcinoma [J].
Chen, Zhitao ;
Lin, Xin ;
Wan, Zhenmiao ;
Xiao, Min ;
Ding, Chenchen ;
Wan, Pengxia ;
Li, Qiyong ;
Zheng, Shusen .
GENES, 2022, 13 (05)
[6]  
Chi Y, 2020, THESIS JILIN U CHANG, DOI [10.27162/d.cnki.gjlin.2020.004068, DOI 10.27162/D.CNKI.GJLIN.2020.004068]
[7]   PDL1 Regulation by p53 via miR-34 [J].
Cortez, Maria Angelica ;
Ivan, Cristina ;
Valdecanas, David ;
Wang, Xiaohong ;
Peltier, Heidi J. ;
Ye, Yuping ;
Araujo, Luiz ;
Carbone, David P. ;
Shilo, Konstantin ;
Giri, Dipak K. ;
Kelnar, Kevin ;
Martin, Desiree ;
Komaki, Ritsuko ;
Gomez, Daniel R. ;
Krishnan, Sunil ;
Calin, George A. ;
Bader, Andreas G. ;
Welsh, James W. .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2016, 108 (01)
[8]   Targeted therapies in gynaecological cancers [J].
Crusz, Shanthini M. ;
Miller, Rowan E. .
HISTOPATHOLOGY, 2020, 76 (01) :157-170
[9]  
Cui Z., 2018, J VASC SURG, V24, P4202
[10]   The Eighth Edition Lung Cancer Stage Classification [J].
Detterbeck, Frank C. ;
Boffa, Daniel J. ;
Kim, Anthony W. ;
Tanoue, Lynn T. .
CHEST, 2017, 151 (01) :193-203